- Home
- BALY vs OCS Comparison
BALY vs OCS Comparison
Compare BALY & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BALY
- OCS
- Stock Information
- Founded
- BALY 2004
- OCS 2003
- Country
- BALY United States
- OCS Switzerland
- Employees
- BALY 10000
- OCS N/A
- Industry
- BALY Hotels/Resorts
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- BALY Consumer Discretionary
- OCS Health Care
- Exchange
- BALY Nasdaq
- OCS Nasdaq
- Market Cap
- BALY 737.4M
- OCS 689.8M
- IPO Year
- BALY N/A
- OCS N/A
- Fundamental
- Price
- BALY $18.04
- OCS $18.27
- Analyst Decision
- BALY Hold
- OCS Strong Buy
- Analyst Count
- BALY 7
- OCS 4
- Target Price
- BALY $18.00
- OCS $30.25
- AVG Volume (30 Days)
- BALY 363.4K
- OCS 48.2K
- Earning Date
- BALY 02-19-2025
- OCS 05-07-2025
- Dividend Yield
- BALY N/A
- OCS N/A
- EPS Growth
- BALY N/A
- OCS N/A
- EPS
- BALY N/A
- OCS N/A
- Revenue
- BALY $2,481,783,000.00
- OCS $757,024.00
- Revenue This Year
- BALY $3.06
- OCS $57.00
- Revenue Next Year
- BALY N/A
- OCS $1,820.89
- P/E Ratio
- BALY N/A
- OCS N/A
- Revenue Growth
- BALY 2.80
- OCS N/A
- 52 Week Low
- BALY $9.74
- OCS $10.79
- 52 Week High
- BALY $18.38
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- BALY 60.77
- OCS 52.53
- Support Level
- BALY $14.67
- OCS $14.00
- Resistance Level
- BALY $15.79
- OCS $16.39
- Average True Range (ATR)
- BALY 2.04
- OCS 0.94
- MACD
- BALY 0.58
- OCS 0.22
- Stochastic Oscillator
- BALY 97.51
- OCS 71.40
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.